Urological Surgeon Awarded American Cancer Society and Pfizer Community Grant

Quoc-Dien Trinh, MD, a urological surgeon at Brigham and Women's Faulkner Hospital, has been awarded the American Cancer Society and Pfizer Community Grant for his research proposal, “Understanding the Drivers of Unequal Receipt of Definitive Therapy for Black Men with Prostate Cancer.”

The American Cancer Society and Pfizer collaborated to create this new, competitive grant opportunity that focuses on addressing prostate cancer disparities impacting Black men and reducing gaps in care and barriers to treatment.;

Trinh was given $250,000 for his proposal to use a comparative case study approach to identify factors, processes, programs and practices associated with the most successful therapy and develop interventions to encourage appropriate care for Black men with prostate cancer in Massachusetts. “The project is a continuation of a long-term collaboration with the Massachusetts Department of Public Health and will allow us to dig deeper into the root causes of disparities in treatment for prostate cancer within Massachusetts,” says Dr. Trinh.

Trinh is Co-Director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center and Director of Ambulatory Clinical Operations for Brigham Health’s Division of Urological Surgery. He is a core faculty and member of the Internal Advisory Board at the Center for Surgery and Public Health, a joint program of Harvard Medical School and the Harvard School of Public Health. He is also the Chair of the Prostate Cancer Workgroup at the Massachusetts Department of Public Health.

The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives and leading the fight for a world without cancer. Pfizer is a biopharmaceutical company committed to funding programs that provide public benefit, advance medical care and improve patient outcomes.